SCHEMBL3046256

SCHEMBL3046256

SC(I)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4223747 0.72
SCHEMBL14930780 0.72
SCHEMBL14560503 0.72
SCHEMBL18077841 0.65
Iodoform SCHEMBL27906049 0.55
Iodoform SCHEMBL28065163 0.55
Iodoform SCHEMBL28140705 0.55
SCHEMBL1036689 0.55
SCHEMBL6800015 0.55
SCHEMBL96926 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359327-B2 Process for the preparation of substituted pyrimidine derivatives JANSSEN PHARMACEUTICA NV (BE) 2016-06-07 US disclosed
US-9079882-B2 Process for the preparation of substituted pyrimidine derivatives JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
US-9079884-B2 Process for the preparation of substituted pyrimidine derivatives JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
US-9006432-B2 Process for the preparation of substituted pyrimidine derivatives JANSSEN PHARMACEUTICA NV (BE) 2015-04-14 US disclosed
US-20140179924-A1 Process for the preparation of cathepsin S inhibitors JANSSEN PHARMACEUTICA NV (US) 2014-06-26 US disclosed
US-20140121374-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (US) 2014-05-01 US disclosed
US-20140073795-A1 Process for the preparation of substituted pyrimidine derivatives JANSSEN PHARMACEUTICA NV (US) 2014-03-13 US disclosed
US-20140066624-A1 Process for the preparation of substituted pyrimidine derivatives JANSSEN PHARMACEUTICA NV (US) 2014-03-06 US disclosed
US-8647878-B2 Highly refractive immersion liquids and their use CARL ZEISS AG (DE) 2014-02-11 US disclosed
US-20130131401-A1 PROCESS FOR THE PREPARATION OF CHYMASE MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2013-05-23 US disclosed
US-20120309986-A1 PROCESS FOR THE PREPARATION OF CHYMASE MODULATORS ANZALONE LUIGI (US) 2012-12-06 US disclosed
US-20120142928-A1 PROCESS FOR THE PREPARATION OF CATHEPSIN S INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2012-06-07 US disclosed
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use CARL ZEISS AG (DE) 2010-08-26 US disclosed
US-20080146759-A1 Sulfur-Containing Compound, Method for Producing Same, Sulfur-Containing Polymer, and Optical Material IDEMITSU KOSAN CO., LTD (JP) 2008-06-19 US disclosed
EP-0409466-B1 Process for the preparation of a polyimide film MITSUI TOATSU CHEMICALS (JP) 1995-04-19 EP disclosed
US-5273998-A Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1993-12-28 US disclosed
US-5260407-A Stretching, pyromellitic acid and 4,4'-bis(3-aminophenoxy) biphenyl MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1993-11-09 US disclosed
US-5177216-A DIASTEREOMERIC ESTER COMPOUND USEFUL AS AN INTERMEDIATE IN THE MAKING OF AN OPTICALLY ACTIVE 3,4-DIHYDRO-3,4-EPOXY-2H-1-BENZOPYRAN COMPOUND YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1993-01-05 US disclosed
EP-0456266-A1 Method for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds, intermediates therefor and uses thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-11-13 EP disclosed
EP-0409466-A2 Process for the preparation of a polyimide film MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-01-23 EP disclosed